Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: A quote from CF "The trial covered only HTC products through 2011"? maybe wrong

I'm just not sure what happens at this pont in regards to willfullness with respect to non-HTC entities because of the NDCA/ITC split decision. It's too far outside of my experience.

Share
New Message
Please login to post a reply